CytoDyn Market Cap

CytoDyn has a market cap or net worth of $332.57 million as of September 29, 2025. Its market cap has increased by 82.02% in one year.

Market Cap

332.57M

Enterprise Value

348.01M

Revenue

n/a

Ranking

n/a

PE Ratio

145.46

Stock Price

$0.26

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 332.57M, an increase of 5,905.70%. That is a compound annual growth rate of 22.89%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	332.57M	147.02%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	789.71M
Elite Pharmaceuticals	742.59M
Tian'an Technology Group	718.73M
Glass House Brands	516.60M
Northwest Biotherapeutics	387.17M
American Oncology Network	305.31M
Nika Pharmaceuticals	301.74M
Silence Therapeutics	261.68M

Market Cap Rankings